Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure.
Anand V KulkarniRaghuram ReddyMithun SharmaSowmya IyengarAnuhya RambhatlaPremkumar GvBalachandran MenonPadaki Nagaraja RaoNageshwar ReddyK Rajender ReddyPublished in: Hepatology international (2023)
LDLT was associated with 73% survival and, thus, is a viable option in those with APASL-defined ACLF. There was a pre-LT high healthcare resource utilization of plasma exchange, with the intention of optimization, while survival benefit has not been demonstrated.